D. E. Shaw & Co., Inc. 23and Me Holding Co. Transaction History

D. E. Shaw & Co., Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$0.96 - $2.01 $6,720 - $14,069	-7,000 Reduced 16.67%	35,000 $34,000
Q2 2023 Aug 14, 2023	BUY	$1.59 - $2.29 $30,305 - $43,647	19,060 Added 83.09%	42,000 $73,000
Q1 2023 May 15, 2023	BUY	$2.05 - $2.87 $47,026 - $65,837	22,940 New	22,940 $52,000
Q2 2022 Aug 15, 2022	SELL	$2.19 - $3.98 $863,363 - $1.57 Million	-394,230 Reduced 35.48%	716,876 $1.78 Million
Q1 2022 May 16, 2022	BUY	$3.28 - $7.12 $2.97 Million - $6.44 Million	905,165 Added 439.53%	1,111,106 $4.26 Million
Q4 2021 Feb 14, 2022	BUY	$6.55 - $13.25 $1.35 Million - $2.73 Million	205,941 New	205,941 $1.37 Million

116

82.5M

404K

292K

Ticker ME
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 259,768,000
Market Cap $795M
Description
23andMe Holding Co. operates as a consumer genetics testing company. It operates through two segments, Consumer & Research Services and Therapeutics. The Consumer & Research Services segment provides a suite of genetic reports, including information on customers' genetic ancestral origins, personal genetic health risks, and chances of pa...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.